{
    "id": 32221,
    "fullName": "NR4A1 positive",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "NR4A1 positive indicates the presence of the NR4A1 gene, mRNA, and/or protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 3164,
        "geneSymbol": "NR4A1",
        "terms": [
            "NR4A1",
            "GFRP1",
            "HMR",
            "N10",
            "NAK-1",
            "NGFIB",
            "NP10",
            "NUR77",
            "TR3"
        ]
    },
    "variant": "positive",
    "createDate": "01/23/2020",
    "updateDate": "01/23/2020",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 19951,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, NR4A1 induced apoptosis and inhibited viability of a NR4A1-expressing colon cancer cell line in culture (PMID: 30926635).",
            "molecularProfile": {
                "id": 34736,
                "profileName": "NR4A1 positive"
            },
            "therapy": {
                "id": 9258,
                "therapyName": "BI1071",
                "synonyms": null
            },
            "indication": {
                "id": 219,
                "name": "colon cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 17623,
                    "pubMedId": 30926635,
                    "title": "BI1071, a Novel Nur77 Modulator, Induces Apoptosis of Cancer Cells by Activating the Nur77-Bcl-2 Apoptotic Pathway.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30926635"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 19950,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, NR4A1 induced apoptosis and inhibited viability of a NR4A1-expressing breast cancer cell line in culture (PMID: 30926635).",
            "molecularProfile": {
                "id": 34736,
                "profileName": "NR4A1 positive"
            },
            "therapy": {
                "id": 9258,
                "therapyName": "BI1071",
                "synonyms": null
            },
            "indication": {
                "id": 1612,
                "name": "breast cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 17623,
                    "pubMedId": 30926635,
                    "title": "BI1071, a Novel Nur77 Modulator, Induces Apoptosis of Cancer Cells by Activating the Nur77-Bcl-2 Apoptotic Pathway.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30926635"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 34736,
            "profileName": "NR4A1 positive",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}